As an investment trust, BioPharma Credit PLC primarily allocates its portfolio to debt assets that generate interest. The security for these investments is provided by royalty payments or other cash flows stemming from the sales of officially approved life sciences products. The firm was established in 2016 and maintains its headquarters in Exeter, United Kingdom.